Cancel Preloader

Bio


Bob is the longest serving Oxford scientist at the Kenyan Programme. Bob’s career began in The Gambia where he undertook the first clinical trials of insecticide treated nets (ITN) [1984-1988]. Following a move to Kenya, he established the framework to undertake linked community-based mortality and hospital admission trials at Kilifi and directed one of four large-scale, community-randomized mortality trials of ITN in Africa [1989-1993]. Subsequently he investigated the possible long-term effects of reduced parasite exposure on the clinical epidemiology of malaria to understand the consequences of sustained ITN use and/or its interrupted use on disease burdens [1994-2003]. This was used as a basis to establish new epidemiological methods to define the mortality, morbidity and consequential burdens posed by malaria in Africa [1995-1999] and clinical disease globally [2005]. As part of new ways to articulate disease burdens he started the Mapping Malaria Risk in Africa (MARA) project with colleagues in South Africa [1996], which served as the model for a global initiative founded by Bob in Nairobi, known as the Malaria Atlas Project (MAP) [2005]. Bob has been supported by the Wellcome Trust since 1992 under three Senior and three Principal Fellowships in Basic Biomedical Science. https://www.tropicalmedicine.ox.ac.uk/news/115-years-of-malaria-in-africa-interview https://www.ndm.ox.ac.uk/bob-snow-malaria-control-in-africa

See more

Current Work


Since 2010, he has led a science-to-policy initiative, funded by DFID, UK, to ensure the best possible use of epidemiological data to design malaria control programmes in 22 African countries. In 2015, this work extended to support countries in the Arabian Peninsula as a collaboration with WHO’s EMR office in Cairo; focusing on countries in conflict, entering phases of malaria elimination, or aiming to prevent malaria re-introduction.

See more

Recent publications


Trends in prevalence and predictors of anemia among school-aged children in Tanzania: analysis of 2019-2023 cross-sectional surveys using a multilevel logistic regression model.
Chacky, F. Rumisha, S. F. Remiji, M. J. Aaron, S. Makori, N. Molteni, F. Walker, P. G. Kyatikila, W. A. Mwingira, F. Wilson, B. Machafuko, P. Mpinga, A. A. Moshi, G. Jumbe, T. Bundala, N. Kawishe, E. Hicks, J. T. McHau, G. Kiware, S. Leyna, G. McHwampaka, W. Saitot, W. Kimaro, O. Silao, J. Ainan, S. Makenga, G. Mkali, H. Kc, A. Chaki, P. Ngasala, B. Nhiga, S. L. Snow, R. W. Van Geertruyden, J. P. Mmbando, B. P.
BMC Public Health, (2026). :

Impact of introducing RTS,S/AS01(E) malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme.
Mwapasa, V. Asante, K. P. Milligan, P. Akech, S. Oduro, A. Mathanga, D. P. Fogelson, A. Kwambai, T. K. Hamel, M. J. Kapito-Tembo, A. Gyan, T. Westercamp, N. Okine, R. N. A. Moore, K. A. Pellaux-Furrer, E. Stanley, C. C. Ansong, D. Kariuki, S. Njuguna, P. Mvalo, T. Welaga, P. Otieno, L. Snell, P. Schellenberg, D. Chimala, A. Afari, E. A. Bejon, P. Maleta, K. Agbenyega, T. Snow, R. W. Zulu, M. Odei-Lartey, E. Chinkhumba, J. Samuels, A. M. Malaria Vaccine Programme Evaluation, partners
Lancet, (2026). 407:1796-1808

Malaria shaped human spatial organization for the past 74 thousand years.
Colucci, M. Leonardi, M. Blinkhorn, J. Irish, S. R. Padilla-Iglesias, C. Kaboth-Bar, S. Gosling, W. D. Snow, R. W. Manica, A. Scerri, E. M. L.
Sci Adv, (2026). 12:eaea2316

A scoping review of antimalarial drug resistance markers in Kenya (1987-2022): toward a National Surveillance Framework and Data Repository.
Wamae, K. Magudha, J. Asiimwe, E. Kimani, K. Kandie, R. Keitany, K. Snow, R. W. Ochola-Oyier, L. I.
Malar J, (2025). 24:413

PHP Code Snippets Powered By : XYZScripts.com